Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2018 /
Regional radiation benefits high risk breast cancer patients

4th - 8th Dec 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.18
Views: 1289

Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK

Prof David Dodwell speaks to ecancer at SABCS 2018 about the role of regional radiation therapy.

He explains that this is radiotherapy that is delivered to the internal mammory chain, the supraclavicular region, or the axilla - or a combination of these target regions.

Prof Dodwell concludes by saying that it was clear from this work that the patients who benefit most from regional radiation are those at higher risk, however the treatment remains controversial.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation